14-day Premium Trial Subscription Try For FreeTry Free
$17.67
+0.0100 (+0.0566%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $14.63 $20.89 Friday, 3rd May 2024 CELC stock ended at $17.67. This is 0.0566% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.80% from a day low at $17.31 to a day high of $17.97.
90 days $13.74 $22.19
52 weeks $8.39 $22.19

Historical Celcuity Inc prices

Date Open High Low Close Volume
May 03, 2024 $17.83 $17.97 $17.31 $17.67 282 961
May 02, 2024 $16.46 $17.99 $16.45 $17.66 154 350
May 01, 2024 $15.84 $16.40 $15.50 $16.30 354 389
Apr 30, 2024 $15.96 $16.26 $15.71 $15.77 117 247
Apr 29, 2024 $15.92 $16.79 $15.85 $16.05 305 970
Apr 26, 2024 $15.92 $16.03 $14.63 $15.92 667 710
Apr 25, 2024 $16.73 $16.76 $15.71 $15.77 219 528
Apr 24, 2024 $17.06 $17.23 $16.91 $16.94 89 644
Apr 23, 2024 $17.56 $18.21 $17.18 $17.24 90 262
Apr 22, 2024 $17.17 $17.67 $16.98 $17.54 403 959
Apr 19, 2024 $16.22 $17.26 $16.17 $17.24 220 869
Apr 18, 2024 $16.76 $16.94 $16.31 $16.39 198 041
Apr 17, 2024 $17.16 $17.40 $16.83 $17.01 117 595
Apr 16, 2024 $17.93 $18.01 $17.19 $17.23 73 093
Apr 15, 2024 $18.20 $18.44 $17.83 $18.09 107 100
Apr 12, 2024 $19.60 $19.60 $18.16 $18.31 240 341
Apr 11, 2024 $19.37 $19.80 $19.31 $19.69 62 786
Apr 10, 2024 $19.39 $19.87 $19.21 $19.38 137 162
Apr 09, 2024 $19.73 $20.15 $19.60 $19.90 169 578
Apr 08, 2024 $20.00 $20.00 $19.06 $19.60 146 669
Apr 05, 2024 $19.67 $20.08 $19.62 $19.97 86 016
Apr 04, 2024 $20.40 $20.89 $19.80 $19.90 241 881
Apr 03, 2024 $19.49 $20.57 $19.43 $20.00 321 068
Apr 02, 2024 $20.49 $20.68 $19.59 $19.64 650 675
Apr 01, 2024 $21.83 $22.04 $20.42 $20.78 230 306
Click to get the best stock tips daily for free!

About Celcuity Inc

Celcuity Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I... CELC Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT